论文部分内容阅读
成立于1992年底并于同年被认证为北京市新技术企业的北京京海生物工程公司,是北京京海集团的成员企业之一。在公司成立后短短的一年半时间里,京海生物工程公司独立研制开发了逆转录PCR方法检测肿瘤耐药基因的RT-PCR诊断试剂盒,对肿瘤耐药基因的表达水平提供了一个重要的检测手段,从而为肿瘤化疗研究和临床应用起到了重要的指导作用,引起很多临床医生、PCR试剂开发和经销者的兴趣。为了推广这项高新技术和产品,公司还分别在北京、上海和张家口等
Beijing Jinghai Bioengineering Co., Ltd., which was established in Beijing at the end of 1992 and has been certified as a new technology enterprise in Beijing, is one of the member companies of Beijing Jinghai Group. In the short period of one and a half years after the establishment of the company, Jinghai Bioengineering Co., Ltd. independently developed a RT-PCR diagnostic kit for reverse-transcription PCR detection of tumor drug resistance genes, providing a The important detection methods have played an important guiding role in the research and clinical application of cancer chemotherapy, which has aroused the interest of many clinicians, PCR reagent developers and distributors. In order to promote this high technology and products, the company also operates in Beijing, Shanghai and Zhangjiakou, respectively.